| Company Name: |
Nantong Hanfang Biotechnology Co. , Ltd.
|
| Tel: |
hanfangpharma@126.com; 18616537568 |
| Email: |
hanfangpharma@126.com |
| Products Intro: |
Product Name:Benzenesulfonamide, 3-[6-amino-5-(2-methyl-5-oxazolyl)-3-pyridinyl]-N-(2-hydroxy-2-methylpropyl)-4-methyl- CAS:1821038-80-5 Purity:98%+ Package:1g;5g;10g;100g; 1kg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PI3Kγ inhibitor 4 CAS:1821038-80-5 Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Benzenesulfonamide, 3-[6-amino-5-(2-methyl-5-oxazolyl)-3-pyridinyl]-N-(2-hydroxy-2-methylpropyl)-4-methyl- manufacturers
- PI3Kγ inhibitor 4
-
- $1520.00 / 25mg
-
2026-03-12
- CAS:1821038-80-5
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Benzenesulfonamide, 3-[6-amino-5-(2-methyl-5-oxazolyl)-3-pyridinyl]-N-(2-hydroxy-2-methylpropyl)-4-methyl- Basic information |
| | Benzenesulfonamide, 3-[6-amino-5-(2-methyl-5-oxazolyl)-3-pyridinyl]-N-(2-hydroxy-2-methylpropyl)-4-methyl- Chemical Properties |
| Boiling point | 603.6±65.0 °C(Predicted) | | density | 1.294±0.06 g/cm3(Predicted) | | pka | 11.09±0.50(Predicted) |
| | Benzenesulfonamide, 3-[6-amino-5-(2-methyl-5-oxazolyl)-3-pyridinyl]-N-(2-hydroxy-2-methylpropyl)-4-methyl- Usage And Synthesis |
| Uses | PI3Kγ inhibitor 4 is a potent, selective and orally active inhibitor of PI3Kγ, with an IC50 of 40 nM. PI3Kγ inhibitor 4 shows ~7, 43, and 18-fold selectivity for PI3Kγ over the α, β, and δ isoforms, respectively. PI3Kγ inhibitor 4 can be used for the research of airway inflammation[1]. | | in vivo | PI3Kγ inhibitor 4 (10-20 mg/kg; a single p.o.) dose dependently inhibits the amplitude of the enhanced pause (ΔPenh) response to ovalbumin in a model of airway inflammation[1]. PI3Kγ inhibitor 4 (a single p.o.) exhibits high oral bioavailability (72, 94 and 122%) and Cmax (1.53, 12.2 and 25.2 μM) following oral administration (10, 100 and 300 mg/kg) in rats[1]. | | IC 50 | PI3Kγ: 40 nM (IC50); PI3Kα: 300 nM (IC50) | | References | [1] Bellenie BR, et, al. Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γ. J Med Chem. 2021 Aug 26;64(16):12304-12321. DOI:10.1021/acs.jmedchem.1c00986 |
| | Benzenesulfonamide, 3-[6-amino-5-(2-methyl-5-oxazolyl)-3-pyridinyl]-N-(2-hydroxy-2-methylpropyl)-4-methyl- Preparation Products And Raw materials |
|